microdosing tirzepatide online Instructions for Compounded Tirzepatide+ Microdosing GLP-1: A Next-Generation Approach

', 2

Diabetologia 2002;45:11111119 EXENATIDE AND LIRAGLUTIDE Effectively reduce HbA1c Preserve beta cell function Promote weight loss Correct known pathophysiologic defects in T2DM Do not cause hypoglycemia Have an excellent safety profile Rad 03/20/00 Triplitt & DeFronzo, Expert Rev Endo Metab 1:329-41, 2006 TIME COURSE OF EFFECT OF EXENATIDE ON HbA1c Time (weeks) 0 20 40 60 80 156 0.5 Placebo Baseline HbA1C=8.3% 0 Exenatide- 10 g bid DeFronzo et al, Diabetes Care 28:1092-1100, 2005 D HbA1c (%) Klonoff et al, Curr Med Res Opin 24:275-285, 2008 -1.0 Exenatide- 10 g bid -2.0 Open-Label Extension Placebo-Controlled Trials EFFECT OF EXENATIDE VERSUS GLARGINE INSULIN ON INSULIN SECRETION IN T2DM Subjects: 59 T2DM

Introduction Finding a medication vial left on the kitchen counter instead of in the refrigerator can cause a moment of immediate panic

Methods 375 , 196206

Stacked Protocol (AOD + MOTS-c) Dose: 0.5 mg AOD + 10 mg MOTS-c (= 20 clicks) Duration: 4 weeks Frequency: Daily Cycle Interval: Optional 2-week pause Goal / Description: 2 weeks off, then repeat or switch to MOTS-c only maintenance Possible Side Effects AOD-9604 is generally well-tolerated in research settings